$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[국내논문] 2'-Fucosyllactose가 마우스 배변 및 장내 미생물에 미치는 영향
Effects of 2'-Fucosyllactyose on Defecation and Intestinal Microbiota in Mice 원문보기

한국식품영양학회지 = The Korean journal of food and nutrition, v.36 no.3, 2023년, pp.193 - 201  

김한해 (한국한의학연구원 UST) ,  김연지 (한국한의학연구원) ,  김광연 (한국한의학연구원) ,  신철수 ((주)에이피테크놀로지) ,  윤종원 ((주)에이피테크놀로지) ,  전선민 ((주)에이피테크놀로지) ,  김보미 ((주)에이피테크놀로지) ,  방정수 ((주)에이피테크놀로지) ,  김경호 (한국한의학연구원)

Abstract AI-Helper 아이콘AI-Helper

Prebiotics are known as components of intestinal microbiota that can improve and maintain human health status by stimulating the growth and activity of the intestinal tract as a method of controlling the intestinal environment. In this study, we examined whether 2'-fucosyllactose (FL) could affect i...

주제어

표/그림 (7)

참고문헌 (50)

  1. Andrews CN, Storr M. 2011. The pathophysiology of chronic?constipation. Can J Gastroenterol 25:169319 

  2. Ballard O, Morrow AL. 2013. Human milk composition:?Nutrients and bioactive factors. Pediatr Clin North Am60:49-74 

  3. Bode L. 2012. Human milk oligosaccharides: Every baby needs a sugar mama. Glycobiology 22:1147-1162 

  4. Bouhnik Y, Raskine L, Simoneau G, Vicaut E, Neut C, Flourie?B, Brouns F, Bornet FR. 2004. The capacity of?nondigestible carbohydrates to stimulate fecal bifidobacteria?in healthy humans: A double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study. Am?J Clin Nutr 80:1658-1664 

  5. Bourlioux P, Koletzko B, Guarner F, Braesco V. 2003. The?intestine and its microflora are partners for the protection of?the host: Report on the Danone Symposium "The Intelligent?Intestine," held in Paris. Am J Clin Nutr 78:675-683 

  6. Deutsch L, Stres B. 2021. The importance of objective stool?classification in fecal 1H-NMR metabolomics: Exponential?increase in stool crosslinking is mirrored in systemic?inflammation and associated to fecal acetate and methionine.?Metabolites 11:172 

  7. Elison E, Vigsnaes LK, Krogsgaard LR, Rasmussen J, Sorensen?N, McConnell B, Hennet T, Sommer MOA, Bytzer P. 2016.?Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and?shifts the intestinal microbiota. Br J Nutr 116:1356-1368 

  8. Facinelli B, Marini E, Magi G, Zampini L, Santoro L, Catassi?C, Monachesi C, Gabrielli O, Coppa GV. 2019. Breast milk?oligosaccharides: Effects of 2'-fucosyllactose and 6'-sialyllactose?on the adhesion of Escherichia coli and Salmonella fyris to?Caco-2 cells. J Matern Fetal Neonatal Med 32:2950-2952 

  9. Farhin S, Wong A, Delungahawatta T, Amin JY, Bienenstock J,?Buck R, Kunze WA. 2019. Restraint stress induced gut?dysmotility is diminished by a milk oligosaccharide (2'-fucosyllactose) in vitro. PLOS ONE 14:e0215151 

  10. Fiordaliso M, Kok N, Desager JP, Goethals F, Deboyser D,?Roberfroid M, Delzenne N. 1995. Dietary oligofructose?lowers triglycerides, phospholipids and cholesterol in serum?and very low density lipoproteins of rats. Lipids 30:163-167 

  11. German JB, Freeman SL, Lebrilla CB, Mills, DA. 2008. Human?milk oligosaccharides: evolution, structures and bioselectivity?as substrates for intestinal bacteria. Nestle Nutr Workshop?Ser Pediatr Program 62:205-222 

  12. Gevers D, Knight R, Petrosino JF, Huang K, McGuire AL,?Birren BW, Nelson KE, White O, Methe BA, Huttenhower?C. 2012. The human microbiome project: A community?resource for the healthy human microbiome. PLOS Biol?10:e1001377 

  13. Gibson GR, Wang X. 1994. Regulatory effects of bifidobacteria?on the growth of other colonic bacteria. J Appl Bacteriol?77:412-420 

  14. Gibson GR. 1999. Dietary modulation of the human gut?microflora using the prebiotics oligofructose and inulin. J?Nutr 129:1438S-1441S 

  15. Good M, Sodhi CP, Yamaguchi Y, Jia H, Lu P, Fulton WB,?Martin LY, Prindle T Jr, Nino DF, Zhou Q, Ma C, Ozolek?JA, Buck RH, Goehring KC, Hackam DJ. 2016. The human?milk oligosaccharide 2'-fucosyllactose attenuates the severity?of experimental necrotising enterocolitis by enhancing?mesenteric perfusion in the neonatal intestine. Br J Nutr116:1175-1187 

  16. Han NS, Kim TJ, Park YC, Kim J, Seo JH. 2012.?Biotechnological production of human milk oligosaccharides.?Biotechnol Adv 30:1268-1278 

  17. Kim BS. 2023. Human Stool image analysis based on deep?learning for smart home healthcare system. Ph.D. Thesis,?Pukyoung National Univ. Busan. Korea 

  18. Kleessen B, Stoof G, Proll J, Schmiedl D, Noack J, Blaut M. 1997. Feeding resistant starch affects fecal and cecal?microflora and short-chain fatty acids in rats. J Anim Sci?75:2453-2462 

  19. Kulinich A, Liu L. 2016. Human milk oligosaccharides: The role?in the fine-tuning of innate immune responses. Carbohydr?Res 432:62-70 

  20. Kwon Y, Lee S. 2002. Effects of Bifidobacteriaand?oligosaccharides on the quality attributes of frozen soy?yogurts. Korean J Soc Food Cookery Sci 18:43-50 

  21. Lee G, Park SS, Lee WC. 1996. A study on the Han, fecal, and?urine in Sasang constitutional medicine. Korean J Orient Int?Med 17:123-138 

  22. Lewis ZT, Totten SM, Smilowitz JT, Popovic M, Parker E,?Lemay DG, Van Tassell ML, Miller MJ, Jin YS, German?JB, Lebrilla CB, Mills DA. 2015. Maternal fucosyltransferase2 status affects the gut bifidobacterial communities of?breastfed infants. Microbiome 3:13 

  23. Maloy KJ, Powrie F. 2011. Intestinal homeostasis and its?breakdown in inflammatory bowel disease. Nature 474:?298-306 

  24. Mao B, He Z, Chen Y, Stanton C, Ross RP, Zhao J, Chen W,?Yang B. 2022. Effects of Bifidobacterium with the ability?of 2'-fucosyllactose utilization on intestinal microecology of?mice. Nutrients 14:5392 

  25. Marriage BJ, Buck RH, Goehring KC, Oliver JS, Williams JA. 2015. Infants fed a lower calorie formula with 2'FL show?growth and 2'FL uptake like breast-fed infants. J Pediatr?Gastroenterol Nutr 61:649-658 

  26. Martinez-Ferez A, Rudloff S, Guadix A, Henkel CA, Pohlentz?G, Boza JJ, Guadix EM, Kunz C. 2006. Goats' milk as a natural source of lactose-derived oligosaccharides: Isolation?by membrane technology. Int Dairy J 16:173-181 

  27. Matsuda K, Akiyama T, Tsujibe S, Oki K, Gawad A, Fujimoto?J. 2021. Direct measurement of stool consistency by texture?analyzer and calculation of reference value in Belgian?general population. Sci Rep 11:2400 

  28. Matsuki T, Yahagi K, Mori H, Matsumoto H, Hara T, Tajima?S, Ogawa E, Kodama H, Yamamoto K, Yamada T,?Matsumoto S, Kurokawa K. 2016. A key genetic factor for?fucosyllactose utilization affects infant gut microbiota?development. Nat Commun 7:11939 

  29. Ministry of Food and Drug Safety. 2020. Functional evaluation?guideline of health functional food. Available from https://www.mfds.go.kr/brd/m_1060/view.do?seq14660&srchFr&srchTo&srchWord%EC%9E%A5+%EA%B1%B4%EA%B0%95&srchTp0&itm_seq_10&itm_seq_20&multi_itm_seq0&company_cd&company_nm&Data_stts_gubunC9999&page1 [cited 22 June 2023] 

  30. Morrow AL, Ruiz-Palacios GM, Altaye M, Jiang X, Guerrero?ML, Meinzen-Derr JK, Farkas T, Chaturvedi P, Pickering?LK, Newburg DS. 2004. Human milk oligosaccharide blood?group epitopes and innate immune protection against?Campylobacter and calicivirus diarrhea in breastfed infants.?In Pickering LK, Morrow AL, Ruiz-Palacios GM, Schanler?RJ (Eds.), Protecting Infants through Human Milk.?Advancing the Scientific Evidence, Vol. 554. pp.443-446.?Springer 

  31. Na MH, Kim WK. 2007. Effects of xylooligosaccharide intake?on fecal Bifidobacteria, lactic acid and lipid metabolism in?Korean young women. J Nutr Health 40:154-161 

  32. Newburg DS, Ruiz-Palacios GM, Altaye M, Chaturvedi P,?Lourdes Guerrero M, Meinzen-Derr JK, Morrow AL. 2004.?Human milk α1,2-linked fucosylated oligosaccharides?decrease risk of diarrhea due to stable toxin of E. coli in?breastfed infants. In Pickering LK, Morrow AL, Ruiz-Palacios GM, Schanler RJ (Eds.), Protecting Infants through?Human Milk. Advancing the Scientific Evidence, Vol. 554.?pp.457-461. Springer 

  33. Ninonuevo M, An H, Yin H, Killeen K, Grimm R, Ward R,?German B, Lebrilla C. 2005. Nanoliquid chromatography-mass spectrometry of oligosaccharides employing graphitized?carbon chromatography on microchip with a high-accuracy?mass analyzer. Electrophoresis 26:3641-3649 

  34. Ogata T, Nakamura T, Anjitsu K, Yaeshima T, Takahashi S,?Fukuwatari Y, Ishibashi N, Hayasawa H, Fujisawa T, Iino?H. 1997. Effect of Bifidobacterium longumBB536?administration on the intestinal environment, defecation?frequency and fecal characteristics of human volunteers.?Biosci Microflora 16:53-58 

  35. Ramirez-Farias C, Baggs GE, Marriage BJ. 2021. Growth,?tolerance, and compliance of infants fed an extensively?hydrolyzed infant formula with added 2'-FL fucosyllactose?(2'-FL) human milk oligosaccharide. Nutrients 13:186 

  36. Rho JH, Kim MH. 2011. Foods, digesting and absorbing. Bull?Food Technol 24:498-524 

  37. Robinson RR, Feirtag J, Slavin JL. 2001. Effects of dietary?arabinogalactan on gastrointestinal and blood parameters in?healthy human subjects. J Am Coll Nutr 20:279-285 

  38. Ruiz-Palacios GM, Cervantes LE, Ramos P, Chavez-Munguia B,?Newburg DS. 2003. Campylobacter jejuni binds intestinal?H(O) antigen (Fucα1, 2Galβ1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and?infection. J Biol Chem 278:14112-14120 

  39. Sharma A, Rao S. 2017. Constipation: Pathophysiology and?current therapeutic approaches. In Greenwood-Van Meerveld B (Ed.), Gastrointestinal Pharmacology. Handbook of?Experimental Pharmacology, Vol. 239. pp.59-74. Springer 

  40. Smith-Brown P, Morrison M, Krause L, Davies PSW. 2016.?Mothers secretor status affects development of childrens?microbiota composition and function: A pilot study. PLOS?ONE 11:e0161211 

  41. Soyyilmaz B, Miks MH, Rohrig CH, Matwiejuk M, Meszaros-Matwiejuk A, Vigsnaes LK. 2021. The mean of milk: A?review of human milk oligosaccharide concentrationsthroughout lactation. Nutrients 13:2737 

  42. Tateyama I, Hashii K, Johno I, Iino T, Hirai K, Suwa Y, Kiso?Y. 2005. Effect of xylooligosaccharide intake on severe?constipation in pregnant women. J Nutr Sci Vitaminol?51:445-448 

  43. Thongaram T, Hoeflinger JL, Chow J, Miller MJ. 2017. Human?milk oligosaccharide consumption by probiotic and human-associated bifidobacteria and lactobacilli. J Dairy Sci 100:7825-7833 

  44. Vazquez E, Barranco A, Ramirez M, Gruart A, Delgado-Garcia?JM, Martinez-Lara E, Blanco S, Martin MJ, Castanys E,?Buck R, Prieto P, Rueda R. 2015. Effects of a human milk?oligosaccharide, 2'-fucosyllactose, on hippocampal long-term?potentiation and learning capabilities in rodents. J Nutr?Biochem 26:455-465 

  45. Vivatvakin B, Mahayosnond A, Theamboonlers A, Steenhout?PG, Conus N. 2010. Effect of a whey-predominant starter?formula containing LCPUFAs and oligosaccharides (FOS/GOS)?on gastrointestinal comfort in infants. Asia Pac J Clin Nutr?19:473-480 

  46. Wang L, Hu L, Yan S, Jiang T, Fang S, Wang G, Zhao J, Zhang?H, Chen W. 2017. Effects of different oligosaccharides at?various dosages on the composition of gut microbiota and?short-chain fatty acids in mice with constipation. Food?Funct 8:1966-1978 

  47. Wheeler RR, Katzmann RA. 2006. A primer on interbranch?relations. Geo L J 95:1155 

  48. Yu ZT, Nanda Nanthakumar N, Newburg DS. 2016. The human?milk oligosaccharide 2'-fucosyllactose quenches Campylobacter jejuni-induced inflammation in human epithelial cells?HEp-2 and HT-29 and in mouse intestinal mucosa. J Nutr146:1980-1990 

  49. Zehra S, Khambati I, Vierhout M, Firoz Mian M, Buck R,?Forsythe P. 2018. Human milk oligosaccharides attenuate?antigen-antibody complex induced chemokine release from?human intestinal epithelial cell lines. J Food Sci 83:499-508 

  50. Zuckerman GR, Trellis DR, Sherman TM, Clouse RE. 1995. An?objective measure of stool color for differentiating upper?from lower gastrointestinal bleeding. Dig Dis Sci 40:1614-1621 

저자의 다른 논문 :

관련 콘텐츠

오픈액세스(OA) 유형

FREE

Free Access. 출판사/학술단체 등이 허락한 무료 공개 사이트를 통해 자유로운 이용이 가능한 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로